AATD

Clinical trials for AATD explained in plain language.

Never miss a new study

Get alerted when new AATD trials appear

Sign up with your email to follow new studies for AATD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Terminated 1

Experimental AATD drug trial ends early — no results yet

Disease control Terminated

This study tested a new medicine, KRRO 110, in healthy people and those with Alpha-1 antitrypsin deficiency (AATD), a genetic condition that can damage the lungs and liver. The goal was to check safety and how the drug moves through the body. The trial was stopped early, so no fi…

Matched conditions: AATD

Phase: PHASE1, PHASE2 • Sponsor: Korro Bio, Inc. • Aim: Disease control

Last updated May 13, 2026 16:03 UTC

AATD

Get alerted when new AATD trials appear

Experimental AATD drug trial ends early — no results yet